Nurix Therapeutics
NRIX
NRIX
117 hedge funds and large institutions have $566M invested in Nurix Therapeutics in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
52% less capital invested
Capital invested by funds: $1.17B → $566M (-$604M)
Holders
117
Holding in Top 10
4
Calls
$2.03M
Puts
–
Top Buyers
| 1 | +$10.4M | |
| 2 | +$8.33M | |
| 3 | +$4.88M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.81M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$4.45M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$12.2M | |
| 3 | -$9.29M | |
| 4 |
TGI
TRV GP III
Boston,
Massachusetts
|
-$7.01M |
| 5 |
O
OrbiMed
New York
|
-$5.34M |